GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Merck KGaA MRK.DE · EUR

Health Care · Pharmaceuticals · XETRA · 🇩🇪 Germany

DAX

Compare

149.20

+0.30%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2025

Revenue

€21.10bn

FY2016FY2025

Net income

€2.61bn

FY2016FY2025

Free cash flow

€2.35bn

FY2016FY2025

Shareholders' equity

€28.59bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue€21.10bn€21.16bn€20.99bn€22.23bn€19.69bn€17.53bn€16.15bn€14.84bn€14.52bn€15.02bn
Gross profit€11.89bn€11.95bn€11.67bn€12.84bn€11.60bn€9.98bn€9.15bn€8.41bn€8.40bn€8.69bn
Research and development€2.38bn€2.27bn€2.44bn€2.45bn€2.40bn€2.29bn€2.26bn€2.20bn€2.11bn€1.97bn
Operating income€4.07bn€4.37bn€4.04bn€5.00bn€4.28bn€3.15bn€2.00bn€1.75bn€2.01bn€2.37bn
Net income€2.61bn€2.78bn€2.82bn€3.33bn€3.06bn€1.99bn€1.32bn€1.13bn€2.60bn€1.63bn
Diluted earnings per share6.006.396.507.657.034.573.042.595.983.74

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets€52.10bn€51.57bn€48.49bn€48.53bn€45.36bn€41.80bn€43.81bn€36.89bn€35.62bn€38.25bn
Cash and short-term investments€2.92bn€2.71bn€2.41bn€1.64bn€1.62bn€1.14bn€570.0m€2.18bn€624.0m€982.0m
Total liabilities€23.44bn€21.58bn€21.74bn€22.52bn€23.95bn€24.78bn€25.90bn€19.66bn€21.55bn€24.20bn
Debt€11.43bn€10.27bn€9.86bn€10.40bn€10.77bn€12.04bn€13.12bn€8.81bn€10.71bn€12.47bn
Shareholders' equity€28.59bn€29.91bn€26.68bn€25.93bn€21.34bn€16.95bn€17.86bn€17.20bn€14.00bn€13.99bn
Shares outstanding435m435m435m435m435m435m434m436m436m435m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations€3.93bn€4.59bn€3.78bn€4.26bn€4.62bn€3.48bn€2.86bn€2.22bn€2.70bn€2.52bn
Capital spending−€1.58bn−€2.18bn−€2.02bn−€1.81bn−€1.42bn−€1.56bn−€1.02bn−€1.02bn−€1.31bn−€848.0m
Free cash flow€2.35bn€2.40bn€1.76bn€2.45bn€3.19bn€1.91bn€1.83bn€1.20bn€1.39bn€1.67bn
Dividends paid−€1.04bn−€284.0m−€1.15bn−€955.0m−€748.0m−€680.0m−€677.0m−€755.0m−€621.0m−€597.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue€5.43bn€5.13bn€5.25bn€5.32bn€5.25bn€5.28bn€5.42bn€5.27bn
Gross profit€3.17bn€3.06bn€2.96bn€3.21bn€3.03bn€3.15bn€3.10bn€3.14bn
Operating income€1.17bn€992.0m€781.0m€1.22bn€908.0m€1.03bn€885.0m€1.27bn
Net income€490.0m€660.0m€319.0m€902.0m€652.0m€735.0m€666.0m€809.0m
Diluted earnings per share1.131.520.732.071.501.691.531.86
Cash from operations€605.0m€818.0m€1.29bn€1.52bn€567.0m€556.0m€1.23bn€1.46bn
Capital spending−€257.0m−€453.0m−€419.0m−€461.0m−€444.0m−€524.0m−€509.0m−€554.0m
Free cash flow€348.0m€365.0m€872.0m€1.06bn€123.0m€32.0m€722.0m€904.0m
Total assets€52.69bn€53.07bn€52.10bn€50.93bn€47.35bn€49.37bn€51.57bn€50.14bn
Cash and short-term investments€1.96bn€3.77bn€2.74bn€2.92bn€1.57bn€1.62bn€2.71bn€3.86bn
Debt€1.09bn€1.24bn€11.44bn€1.65bn€3.10bn€1.73bn€9.65bn€3.51bn
Shareholders' equity€30.17bn€29.74bn€28.59bn€28.94bn€28.26bn€29.82bn€29.91bn€28.32bn

Financial ratios

Data as of 17 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin56.4%56.5%55.6%57.8%58.9%56.9%
Operating margin19.3%20.6%19.3%22.5%21.8%18.0%
Net margin12.4%13.1%13.5%15.0%15.5%11.3%
Return on equity9.1%9.3%10.6%12.8%14.3%11.7%
Return on assets5.0%5.4%5.8%6.9%6.7%4.8%
Free cash flow yield9.6%11.8%10.1%10.5%10.5%8.8%
Revenue growth-0.3%0.8%-5.6%12.9%12.3%8.6%
Earnings growth-6.1%-1.7%-15.1%8.8%53.7%50.5%
Current ratio1.46x1.19x1.42x1.28x1.05x1.01x
Debt to equity0.40x0.32x0.36x0.39x1.56x0.69x
Equity ratio54.9%58.0%55.0%53.4%47.0%40.5%
Interest coverage15.52x20.70x15.85x25.75x17.55x8.14x
R&D as a share of sales11.3%10.7%11.6%11.0%12.2%13.0%
Buybacks as a share of market value0.0%0.0%0.0%0.0%0.1%-0.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.7%3.8%5.1%
Operating income-6.6%5.2%6.8%
Net income-7.8%5.6%8.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin56.4%56.6%57.0%57.4%
Operating margin20.0%20.4%20.3%17.9%
Net margin12.7%13.5%13.5%12.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings20.421.922.223.632.330.734.634.715.026.5
Price to sales2.52.93.03.55.03.52.82.62.72.9

Dividends and splits

Per share, in the currency the company pays

Paid for 30 years. Last went ex-dividend on 27 Apr 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year2.202.202.202.201.851.401.301.25
  • 2-for-1 split · 30 Jun 2014
  • 1-to-1 reverse split · 1 Dec 1998

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.